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Abstract
Introduction: Although crystalloid-perfused isolated heart models are widely used in cardiovascular research, there are several limitations of
these techniques. Changes in cardiac gene expression pattern due to normoxic perfusion itself have not been studied, despite its potential
importance to provide useful information on limitations of this model. Therefore, here we investigated the time-dependent effect of normoxic,
normothermic perfusion on global gene expression at mRNA and protein levels.Methods: Hearts from male CFLP mice were perfused according
to the Langendorff technique. We assessed relative gene expression changes by DNA microarray analysis of 8000 genes after 0, 60 and 120 min
perfusion. Results: Twelve genes exhibited significant up-regulation and 27 showed repression in hearts perfused for 60 or 120 min as compared
to 0 min controls. Expression changes of 17 selected genes were verified and an additional 19 genes were examined by real-time quantitative PCR.
Genes with altered expression included those coding for Creatin kinase, Lactate dehydrogenase, Voltage-dependent anion channel 1, a Disintegrin
and Metalloprotease domain 3, Integrin alpha 7, Long-chain acyl-CoA dehydrogenase, Casein kinase II, Ketohexokinase, Chloride ion current
inducer protein, Matrix metalloproteinase 2 and 9, Superoxide dismutases and Nitric oxide synthases, etc. Discussion: Our results show that
normoxic crystalloid perfusion itself results in time-dependent changes in cardiac gene expression which should be considered when designing ex
vivo perfusion protocols in the mouse heart to mimic cardiac pathologies as many of these genes have been suspected to influence several
cardiovascular diseases.
© 2008 Elsevier Inc. All rights reserved.
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1. Introduction
The isolated perfused heart is one of the most widely used
experimental models in cardiovascular research, including
testing drug efficacy and safety and modeling cardiovascular
pathologies such as ischemia-reperfusion injury. It is a relatively
simple model and it provides a highly reproducible preparation
which can be used for comprehensive examinations of cardiac
contractile function, electrophysiology, cellular biochemistry
and molecular biology. However, the major limitations of this
model include deterioration of myocardial function within
beyond 60 min possibly due to oxidative and nitrosative stress
(Ferdinandy, Panas, & Schulz, 1999) and unusual appearance of
cardiac arrhythmias (Clements-Jewery, Hearse, & Curtis, 2002;
Curtis, 1998; Hearse, Richard, Yellon, & Kingma, 1988;
Miyashita et al., 2000; Ravingerova, Pancza, Ziegelhoffer, &
Styk, 2005; Schomisch et al., 2005). Although the most
frequently used ex vivo heart preparation is the rat heart, due
to the lower cost and the appearance of the genetically modified
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mice, ex vivo mice heart preparations have been rapidly spread-
ing in the scientific community.
Unfortunately, although the literature contains an increasing
number of studies employing mouse hearts, the fundamental
characteristics of that have yet to be completely characterized
(Sutherland & Hearse, 2000). In our study we used isolated and
perfused mouse hearts. Hearts were excised, mounted on the
Langendorff apparatus and perfused. Despite of several studies
employing Langendorff perfusion in rat hearts (Onody et al.,
2003; Puskás et al., 2004), still very little is known about the
gene expression pattern of the heart in response to ischemia-
reperfusion after different periods of time. Without the knowl-
edge of gene expression changes at mRNA and protein levels in
the perfused heart, it is difficult to define specific controls and
these variations could alter the results of different studies.
Therefore we have tried to answer such questions as: what are
the effects of oxygenated perfusion fluid on global gene
expression and how does it change related to time. To profile
gene expression patterns at mRNA level, we monitored global
gene expression changes by DNA microarray analysis (Onody
et al., 2003) and validated the results by quantitative real-time
polymerase chain reaction (QRT-PCR) in the mouse hearts. We
studied the importance of perfusion time. The effects of 60 and
120 min perfusion were also studied and transcriptional changes
were evaluated. Furthermore, two enzyme-activity measure-
ments for lactate dehydrogenase and creatine kinase activities
were investigated.
2. Materials and methods
2.1. Perfusion protocol of isolated mouse hearts
Male CFLP mice (35–45 g) were anesthetized with
diethylether and given 150 U heparin ip. Hearts were then
isolated and perfused in Langendorff mode (at a constant
pressure of 70 mm Hg, 37 °C) with Krebs–Henseleit buffer
containing (in mmol/L) 118 NaCl, 25 NaHCO3, 4.7 KCl, 1.2
MgSO4, 1.2 KH2PO4, 1.75 CaCl2, and 11.1 glucose, oxyge-
nated with 95% O2–5% CO2 (pH=7.4) as described (Csont
et al., 2005; Giricz, Csonka, Onody, & Csont, 2003). To
investigate the effect of the extent of ex vivo perfusion on the
changes of gene expression pattern of mouse hearts three
different perfusion protocols were applied (n=5–8 in each
group). Hearts were subjected to either a 5 min wash out period,
or a 60 min or 120 min normothermic, aerobic perfusion. Heart
rate and coronary flow were monitored throughout the perfusion
protocol in all groups. At the end of the perfusion protocol,
hearts from all groups were frozen and crushed at the
temperature of liquid nitrogen.
2.2. RNA isolation
RNAwas purified from each group (76–100 mg tissue from
each heart) Samples were rotor-homogenized and treated with
proteinase-K (Qiagen). Total RNA was extracted with RNeasy
Fibrous Tissue Mini Kit (Qiagen) according to the manufac-
turer's instructions (Onody et al., 2003). Prepared RNA samples
from each group were pooled, and their quantities and qualities
were assessed spectrophotometrically. The same total RNA
pool was used for microarray analysis and for QRT-PCR.
2.3. Microarrays, sample preparations and hybridizations
Construction and use of microarrays were performed as
described previously (Puskás, Zvara, Hackler, Micsik & van
Hummelen, 2002). 2 μg of total RNA was reverse transcribed
(Fermentas, RevertAid H Minus M-MuLV Reverse Transcrip-
tase) according to the manufacturer's instruction. cDNA with
Cy5 capture sequence was hybridized onto mouse microarray
containing 8000 mouse specific cDNA probes. All the other
sample preparation steps were done according the manufac-
turer's instructions (Genisphere). Both the first step cDNA
hybridization and the second step capture reagent hybridization
were carried out in a Ventana hybridization station (Ventana
Discovery, Tucson, AZ) by using the “antibody” protocol. First
hybridization was performed at 40 °C for 6 h in “FGL2”
hybridization buffer (10×Denhardt's solution, 0.25 M sodium
phosphate buffer pH 7.0, 1 mM EDTA, 1×SSC, 0.5% SDS),
and then 2.5 μl of each Cy5 and Cy3 capture reagents were
added to the slides in 200 μl “ChipHybe” hybridization buffer
(Ventana) and incubated at 42 °C for 2 h. After hybridization
slides were washed in 0.2×SSC twice at room temperature for
10 min and then dried and scanned.
2.4. Scanning and data analysis
Each array was scanned under a red laser (633 nm for Cy5
labeling) using a ScanArray Lite (GSI Lumonics, Billerica,
MA) scanning confocal fluorescent scanner with 10 μm
resolution. Scanned output files were analyzed using GenePix
Pro5.0 software (Axon Instruments Inc., Foster City, CA). Each
spot was defined by automatic positioning of a grid of circles
over the image. For each channel, the median values of feature
and local background pixel intensities were determined (Palotas
et al., 2004). The background corrected expression data were
filtered for flagged spots and weak signals. Technical replicates
on the same array were averaged. Data were excluded in cases
where technical replicates were significantly different. Normal-
ization was performed using the print-tip LOWESS method
(Yang et al., 2002). Next, we used the one-sample t test to
determine the genes to be regarded as regulated in response to
treatment. Logarithm was taken from each expression ratio to
fulfill the requirement of the t test for a normal distribution.
Genes for which the mean of log ratios across the biological
replicates were equal to zero at a significance level (α=0.05) are
considered to have an unchanged expression. On the other hand,
genes having a p value smaller than α and the average fold
change (increase or decrease) of the four data points were at
least 1.9 times were considered as regulated genes.
2.5. Quantitative real-time polymerase chain reaction (QRT-PCR)
QRT-PCR was performed on a RotorGene 3000 instru-
ment (Corbett Research, Sydney, Australia) with gene-specific
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primers and SybrGreen protocol to confirm expression changes
of 17 selected genes observed by microarrays. An additional 19
genes strongly related to cardiac stress adaptation and ischemia/
reperfusion injury, but not available on the microarray were also
investigated by QRT-PCR.
Two μg of total RNA from each sample were reverse
transcribed in the presence of random primers in a total volume
of 20 μl. After dilution with 20 μl of water, 1 μl of the diluted
reaction mix was used as template in QRT-PCR. The 20 μl
reaction volume contained 0.2 mM of dNTP, 1×PCR reaction
buffer (ABGene, Epsom, UK), 6 mM of each primer, 4 mM of
MgCl2, 1×SYBR Green I (Molecular Probes, Eugene, OR) at
final concentration, and 0.5 U of thermostart Taq DNA
polymerase (ABGene). Amplification was carried out with the
following cycling parameters: 600 s heat start at 95 °C, 45 cycles
of denaturation at 95 °C for 25 s, annealing at 60 °C for 25 s, and
fluorescence detection at 72 °C for 15 s. After amplification, a
melting curve was created to verify the specificity of PCR
reactions. Relative expression ratios were normalized to
GAPDH, as a widely used housekeeping gene. The PCR
primers used in this study are listed in Table 1.
2.6. Myocardial lactate dehydrogenase (LDH) and creatine
kinase (CK) activities
In order to further investigate whether changes in cardiac
gene expression due to differences in ex vivo perfusion time
leads to alterations at the protein level enzyme activities of LDH
and CK were determined from cardiac tissue. Ventricular tissue
was homogenized as described previously (Gao et al., 2003).
Both LDH and CK activities were determined by a spectro-
photometric kinetic analysis at 340 nm using commercially
available diagnostic kits (Diagnosticum Rt., Budapest, Hun-
gary) according to the instructions of the manufacturer. Enzyme
activities were normalized to the total protein content of the
homogenates and expressed as mU/mg protein.
3. Results
3.1. Gene expression alteration due to perfusion
Using DNA microarray technology, we analyzed 8000 genes
for changes in expression associated with the perfusion related
to incubation time. Relative gene expression changes in mouse
hearts in response to 60 and 120 min perfusion were compared
to the expression profile of the control animals. Among the
8000 genes examined in the present study 39 genes showed
altered expression. We selected 17 genes (Table 1) of which the
expression were significantly altered in the heart due to 60 or
120 min perfusion for QRT-PCR analysis. Out of these, two
genes exhibited significant up-regulation and 15 were down-
regulated (Table 2).
Gene coding for Glucosaminyl-N-deacetylase/N-sulfotrans-
ferase 2 (Ndst2), responsible for HS N-sulfation was repressed
after 60 and 120 min of perfusion.
Another gene related to glycosphingolipid biosynthesis was
also repressed: beta-1,4-N-acetyl-galactosaminyl transferase 1
with a 1.52 fold repression after 60 min of perfusion.
Perfusion altered the expression of three genes having a role
in the regulation of cell cycle. Casein kinase II was over-
expressed after 60 min, however, QRT-PCR analysis could not
confirm this induction. After 120 min, changes were normalized
to control level both in microarray and QRT-PCR.
Changes in the expression of other cell cycle regulatory genes
showed repression, which was also confirmed by QRT-PCR.
G two S phase expressed protein 1 (previously named as B99)
had only shown down-regulation after 120min of perfusion. The
expression of Ketohexokinase (Khk) was significantly declined
after 60 and also 120 min of perfusion.
A key enzyme of the glycolysis, Lactate dehydrogenase A-4
was down-regulated in response to perfusion.
Gene coding for long-chain acyl-CoA dehydrogenase
(LCAD) was significantly down-regulated after 2 h of perfusion.
Table 1
Primers used in quantitative real-time polymerase chain reaction (QRT-PCR) analysis
Gene product Accession number Forward primer Reverse primer
N-deacetylase/N-sulfotransferase NM_010811 TGATGACAAGAGGCACAAAGA AAGAAGTGAATAGCCGTGGTG
Beta-1,4-N-acetyl-galactosaminyl transferase 1 NM_008080 GCCAACACAGCAGACACAGT GAGGATGGTGAAGGCAACTT
G two S phase expressed protein 1 NM_013882 TTCACCTGGCTACAGAGAAGC TCACGAGTTTCGTCCTCTGA
Microtubule-associated protein 1 NM_007896 GTTCAGCCCCTGATGTGTTT GGTCACAGGGAGCAGAGAGA
Ketohexokinase NM_008439 CATCATCAATGTGGTGGACAA TGCCATCTCTGGGACAGG
Integral membrane protein 2B NM_008410 CTGAACACTTCCATCGTTATGC GGTAGGACTGAGGCAGGTAGG
Casein kinase II, alpha 2 NM_009974 AAGTATAGTGAAGTATTTGAGGCCATT TCGTTTTATCTTCTTTTTCTTCACTG
A disintegrin and metalloprotease domain 3 NM_009619 GAAAATCGACACCAACATCCA CCCTCAATTGTGACCACGTA
Troponin T1 NM_011618 ATCTGTGGACCCAGCCTTAG GCCTGCTCCTCCTCATATTCT
Acetyl-Coenzyme A dehydrogenase, long-chain NM_007381 AAGTGATTCCTCACCACACAGA CAGCTTTTTCCCAGACCTCTC
Integrin alpha 7 NM_008398 AAGTGCCATGCGATCTGAG GACTGGCCTTGATTGGAGAC
Chloride ion current inducer protein U53455 TGAACCCATTTCTGAATTTCG GTGAACATCGCCTCCAATG
Protein phosphatase 1 inhibitor 14B NM_008889 CTCACGCGACTCTACGACTG CCATGTCTAAAAGTTCATCCACA
Interleukin 12 receptor, beta 1 NM_008353 CAGCCGAGTGATGTACAAGG TAAACGGGAAATCTGCACCT
Creatine kinase, muscle NM_007710 CAGCACAGACAGACACTCAGG GAACTTGTTGTGGGTGTTGC
Voltage-dependent anion channel 1 NM_011694 ACCTTTGATTCGTCATTCTCG TGCTCCCTCTTGTACCCTGT
Lactate dehydrogenase A-4 M17518 CTGCCAACTGTATGCAGTCTTT ATGTTTGGTGAGGGTGTGC
To confirm the differential expression of genes of perfused mouse hearts revealed by microarray analysis we selected 17 genes for QRT-PCR analysis.
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Decreased transcription activity of gene for Chloride ion current
inducer protein was detected after 60 and 120 min of normoxic
perfusion.
Genes, encoding two apoptotic proteins presented significant
repression in response to perfusion: Integral membrane protein
2B and Voltage-dependent anion channel 1 (Vdac1). As the
microarray and the QRT-PCR results evidenced, repression is
more pronounced over the increase of perfusion time.
Perfusion repressed several genes including some signal
transduction genes. One of them, the integrin alpha 7 didn't
show altered expression after 60 min of perfusion, but after
120 min, it was strongly repressed. The interleukin 12 receptor
beta-1 subunit gene was also strongly attenuated at the mRNA
level in comparison to the control group even after 60 min
perfusion.
A disintegrin and metalloprotease domain 3 (adam3) had a
very significant rise in transcription rate. Protein phosphatase 1
regulatory subunit 14B became repressed only after 120 min of
perfusion.
Two genes have shown altered expression among the muscle
contraction regulators. Our results show that 60 and 120 min of
perfusion also induced repression of Creatine kinase muscle
(Ckmm). The repression rate of Troponin T1, skeletal (Tnnt1)
grows with the increase of perfusion time.
3.2. Expression profiling of genes related to ischemic
adaptation
Measurement of expression at mRNA level of an additional
19 genes strongly related to cardiac adaptation to ischemia-
reperfusion but not available on the microarrays was also
investigated by QRT-PCR (Table 3).
Superoxide dismutase (SOD) enzyme catalyzes the reduc-
tion of superoxide anions to hydrogen peroxide, as such, it is an
important antioxidant. Three superoxide dismutases are char-
acterized by different metal content. According to our results
Fig. 1. CK and LDH enzymatic activity measurements. According to the
microarray and QRT-PCR analysis, creatine kinase (ck) and lactate dehydro-
genase (ldh) genes are being repressed after 60 and 120 min of perfusion. CK
and LDH enzymatic activities in the heart extracts were determined to detect
decline in gene expression of genes coding for these enzymes. * p=0.06.
Table 2
Comparison of gene expression changes observed by microarray and quantitative real-time RT-PCR
Gene product Accession
number
Ratio (SD)
chip 60′
Ratio (SD)
QRT-PCR 60′
Confirmed by
QRT-PCR
Ratio (SD)
chip 120′
Ratio (SD)
QRT-PCR 120′
Confirmed by
QRT-PCR
N-deacetylase/N-sulfotransferase 2 NM_010811 −1.27 (0.54) −1.69 (0.20) Yes −1.11 (0.43) −1.25 (0.35) Yes
Beta-1,4-N-acetyl-galactosaminyl
transferase 1
NM_008080 −1.52 (0.37) −1.8 (0.14) Yes −1.06 (0.26) −2.17 (0.20) Yes
G two S phase expressed protein 1 NM_013882 −1.25 (0.33) −1.44 (0.29) Yes +0.36 (0.33) −1.80 (0.19) No
Microtubule-associated protein, RP/EB
family, member 1
NM_007896 −1.24 (2.16) −2.01 (0.25) Yes −2.11 (1.32) −1.87 (0.37) Yes
Ketohexokinase NM_008439 −1.24 (0.77) −2.28 (0.84) Yes −0.56 (0.87) −2.03 (0.50) Yes
Integral membrane protein 2B NM_008410 −1.24 (1.24) −2.02 (0.55) Yes −0.70 (1.40) −1.25 (0.23) Yes
Casein kinase II, alpha 2, polypeptide NM_009974 +1.08 (0.29) −2.84 (0.36) No +0.14 (0.31) −3.38 (0.32) No
Disintegrin and metalloprotease
domain 3 (cyritestin)
NM_009619 +1.19 (0.65) −0.83 (0.09) No +1.37 (0.41) −1.03 (0.17) No
Troponin T1, skeletal, slow NM_011618 −1.08 (0.75) −1.30 (0.43) Yes −1.60 (0.54) −2.44 (0.48) Yes
Acetyl-Coenzyme A dehydrogenase,
long-chain
NM_007381 −0.72 (0.70) −3.25 (1.52) Yes −1.54 (0.62) −4.03 (1.73) Yes
Integrin alpha 7 NM_008398 −0.26 (0.87) +4.06 (1.37) No −1.33 (0.97) −2.82 (1.24) Yes
Chloride ion current inducer protein U53455 −1.39 (1.32) −5.42 (0.83) Yes −1.27 (2.20) −6.04 (1.21) Yes
Protein phosphatase 1, regulatory
(inhibitor) subunit 14B
NM_008889 −0.12 (0.41) −0.51 (0.23) No −1.06 (1.14) −1.32 (0.24) Yes
Interleukin 12 receptor, beta 1 NM_008353 −3.20 (3.48) −1.26 (0.32) Yes −0.72 (1.46) −1.57 (0.29) Yes
Creatine kinase, muscle NM_007710 −1.51 (0.61) −1.47 (0.24) Yes −1.15 (0.54) −1.95 (0.02) Yes
Voltage-dependent anion channel 1 NM_011694 −1.43 (0.38) −2.61 (n.d.) Yes −2.66 (0.50) −2.01 (n.d.) Yes
Lactate dehydrogenase A-4 M17518 −0.63 (0.32) −0.81 (n.d.) Yes −0.92 (0.75) −1.28 (n.d.) Yes
Relative gene expression changes in mouse hearts in response to 60 and 120 min perfusion were compared to the expression profile of the control animals by
microarray and quantitative real-time polymerase chain reaction (QRT-PCR) analysis. Two genes exhibited significant up-regulation and 15 were down-regulated.
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each types of sod represents over-expression after 60 and
120 min of perfusion.
The NADPH oxidase is a multi-subunit enzyme that
catalyzes the reduction of molecular oxygen to form super-
oxide. According to our results, the over-expression of NOX
enzymes (and in this way the amount of reactive oxygen
species) increases directly proportional to perfusion time.
We observed increasing activity in case of two matrix
metalloproteinase genes, mmp2 and mmp9. Genes coding for
Matrix metalloproteinases 2 and 9 (MMP2 and MMP9) were
overexpressed due to perfusion in both groups.
We have also detected increasing expression of low density
lipoprotein gene after 60 and 120 min.
Among the four tissue inhibitor of metalloproteinase (timp)
genes investigated in our study, only inhibitor of metalloprotei-
nase-1 showed altered expression. We observed about 1.80 fold
over-expression after 60 and 120 min of perfusion.
The Nitric oxide synthases (NOS) are a group of enzymes
responsible for the synthesis of nitric oxide (NO) from the
terminal nitrogen atom of L-arginine in the presence of O2 and
certain cofactors. The nitric oxide molecule is a free radical, that
makes it very reactive and unstable and in high concentration it
has cytotoxic effects. We have shown that perfusion inhibits
expression of cardiac nitric oxide synthases 2 (nos2).
Our results show that 60 and 120 min of perfusion induced
over-expression of gene for 25-kDa Heat shock protein
(HSP25).
Geranyl geranyl transferase, HMG-CoA reductase, farnesyl
diphosphate farnesyl transferase 1 and NADH dehydrogenase
have been studied previously in response to ischemia-reperfusion.
One of them, the NADH dehydrogenase didn't show altered
expression after perfusion. At the other three genes we confirmed
up-regulation of transcription due to perfusion.
3.3. Enzymatic activities
CK and LDH activities in the heart extracts (n=4 in each
group) were also determined as we could detect decline in gene
expression of genes coding for these enzymes. According to the
microarray analysis and QRT-PCR results, ck and ldh genes are
being repressed after 60 and 120 min of perfusion and this rate of
repression is more pronounced over the increase of perfusion
time. The enzyme activity measurements (results are shown in
Fig. 1) showed that creatine kinase and lactate dehydrogenase
levels were also decreased due to perfusion.
Hemodynamic parameters, like coronary flow and heart rate
were also measured. None of these parameters changed in the
perfused groups (Table 5) when compared to controls.
4. Discussion
4.1. Gene expression alteration due to perfusion
Perfusion leads to extensive changes in cardiac expression of
genes from various functional clusters (Table 4). As shown in
Table 5, heart rate and coronary flow were not changed in the
perfused groups.
Our present study is the first demonstration in connection
with the effects of different long periods of perfusion time in
mouse hearts. The role of most genes found to be regulated by
Table 3
Measurement of expression ratio at mRNA level by QRT-PCR
Gene product Accession
number
Forward primer Reverse primer Ratio (SD)
60′
Ratio (SD)
120′
Superoxide dismutase-1 NM_011434 TTTTTTTGCGCGGTCCTTT ACCAGAGAGAGCAAGACGAGAAG 1.00 (0.79) 1.07 (0.93)
Superoxide dismutase-2 NM_013671 TTAACGCGCAGATCATGCA GGTGGCGTTGAGATTGTTCA 1.05 (1.77) 1.15 (0.81)
Superoxide dismutase-3 NM_011435 CATGCAATCTGCAGGGTACAA CGGTGATCTGCGGCTGAT 0.84 (1.42) 1.27 (1.17)
NADPH oxidase-1 NM_172203 CCCAGCAGAAGGTCGTGATT CCTCATCTGCAATTCCAAAACA 1.87 (1.13) 3.15 (1.68)
NADPH oxidase-4 BC021378 GATTTCTGGACCTTTGTGCCTTT TGATGGTGACAGGTTTGTTGCT 0.84 (0.26) 0.31 (0.27)
Nitric oxide synthase 1 NM_008712 CACCCACCAAAGCTGTCGAT CTGCTAATGGCTGGTCTTTGC 1.04 (0.65) 0.66 (4.17)
Nitric oxide synthase 2 NM_010927 GGCAGCCTGTGAGACCTTTG CATTGGAAGTGAAGCGTTTCG 0.25 (0.57) 0.18 (0.28)
Matrix metalloproteinase-2 NM_008610 CCCATGAAGCCTTGTTTACCA TGGAAGCGGAACGGAAACT 1.20 (0.24) 1.61 (0.32)
Tissue inhibitor of
metalloproteinase 1
NM_011593 GCAAAGAGCTTTCTCAAAGACC AAGGGATAGATAAACAGGGAAACA 1.75 (0.55) 1.86 (0.88)
Tissue inhibitor of
metalloproteinase 2
NM_011594 CGTTTTGCAATGCAGACGTA GGAATCCACCTCCTTCTCG 0.70 (0.35) 0.52 (0.10)
Tissue inhibitor of
metalloproteinase 3
BC014713 GCCTCAAGCTAGAAGTCAACAAA TGTACATCTTGCCTTCATACACG 0.79 (1.12) 1.02 (0.78)
Tissue inhibitor of
metalloproteinase 4
NM_080639 AGGGAGAGCCTGAATCATCA GCACTGCATAGCAAGTGGTG 0.97 (1.04) 0.33 (0.93)
HMG-CoA reductase NM_008255 TCTGGCAGTCAGTGGGAACTATT CCTCGTCCTTCGATCCAGTTT 1.18 (0.19) 1.19 (0.25)
Farnesyl diphosphate farnesyl
transferase 1
BC054722 TGAACTCATAACCAACACCCTACAG TGGTTCCGGAGCCTTGAC 1.07 (1.26) 1.07 (0.89)
Heat shock protein 25 kDa 2 AK030025 AGCTCACAGTGAAGACCAAGG CATGTTCGTCCTGCCTTTCT 1.38 (1.11) 1.20 (0.80)
NADH dehydrogenase BC081434 GCTTGCTTCGGTACAAAACG GGGGTGTATTTGCCCTCTTT 0.37 (0.45) 0.89 (0.45)
Geranyl geranyl transferase BC012214 TGCTAAATGGCCAGACAGTCAT TGAGTGACAGGCCGCAGAT 1.18 (0.77) 1.39 (1.10)
Low density lipoprotein NM_010700 GATGGCTATACCTACCCCTCAA TGCTCATGCCACATCGTTC 1.11 (1.02) 1.14 (0.72)
Matrix metalloproteinase-9 NM_013599 ACGACATAGACGCCATCCA GCTGTGGTTCAGTTGTGGTTG 1.20 (0.26) 1.55 (0.51)
The expression of an additional 19 genes strongly related to ischemia-reperfusion but that were not available on the microarrays was also investigated by QRT-PCR (in
normoxic perfused mouse hearts related to control).
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perfusion is not exactly known in the heart, therefore, our
present findings may open new directions in research of the
cardiac effects of perfusion.
Enzymatic activity measurements proved that perfusion
decreased significantly the LDH and CK activity correlating to
the non-perfused control group and that was confirmed by
microarray results.
Heparan sulfate (HS) proteoglycans influence embryonic
development through interactions with growth factors and
morphogens. Interactions depend on HS structure that is largely
determined by biosynthesis in Golgi (Holmborn et al., 2004).
Glucosaminyl-N-deacetylase/N-sulfotransferase 2 (Ndst2),
responsible for HS N-sulfation, is the key enzyme directing
further modifications including O-sulfation. This gene product
hasn't been correlated with ischemia or perfusion yet (Carter,
Ali, & Kirby, 2003).
Galgt1 is an important determinant of plasma VWF (von
Willebrand factor) levels in mouse (Ginsburg, 2005; Mohlke
et al., 1999).
Changes in the expression of other cell cycle regulatory
genes showed down-regulation, which were also confirmed by
QRT-PCR. Some studies have already demonstrated that the
gene, encoding Microtubule-associated protein 1 shows altered
expression in response to the developement of ischemia in the
rat retina (Mastrodimou, Lambrou, & Thermos, 2005) and in
response to autophagy in chronically ischemic myocardium
(Yan et al., 2005). According to our results, the repression of
Mtap1 increases directly proportional to time of normoxic
perfusion.
Gtse1 (previously named B99) showed down-regulation
after only 120 min of perfusion. This is a wt-p53 inducible gene
that encodes a microtubule-localized protein which is able to
induce G(2)/M phase accumulation when ectopically expressed.
The function of Gtse1 in the myocardium is presently unknown.
Ketohexokinase 1 catalyses the phosphorylation of fructose
to fructose-l-phosphate. Khk expression had a significant
decline after 60 and also 120 min of perfusion. This enzyme
is expressed predominantly in the liver, to a lesser extent in the
kidney, and very little in heart, brain and muscle (Bais, James,
Rofe, & Conyers, 1985).
A key enzyme of the glycolysis, lactate dehydrogenase A-4 is
a well-established marker of cardiac damage. Karaca studied the
expression alteration of lactate dehydrogenase gene, induced by
ischemia-reperfusion. They previously proved that the expres-
sion of ldh gene rises in response to ischemia (Karaca et al.,
2006; Xu et al., 2006), but at the same time our results have
shown that in response to normoxic perfusion LDH was down-
Table 4
Functional classification of differentially expressed genes
Functional cluster Gene product Accession
number
Oxidative and nitrosative
stress
Superoxide dismutase-1 NM_011434
Superoxide dismutase-2 NM_013671
Superoxide dismutase-3 NM_011435
NADPH oxidase-1 NM_172203
NADPH oxidase-4 BC021378
Nitric oxide synthase 1 NM_008712
Nitric oxide synthase 2 NM_010927
Heat shock proteins Heat shock protein 25 kDa 2 AK030025
Energy metabolism Creatine kinase, muscle NM_007710
NADH dehydrogenase BC081434
Lactate dehydrogenase A-4 M17518
Acetyl-Coenzyme A
dehydrogenase, long-chain
NM_007381
Cholesterol synthesis,
transport
HMG-CoA reductase NM_008255
Low density lipoprotein NM_010700
Farnesyl diphosphate
farnesyl transferase 1
BC054722
Geranyl geranyl transferase BC012214
Muscle contraction Troponin T1, skeletal, slow NM_011618
Ion channels, receptors,
membrane proteins
Voltage-dependent anion channel
1
NM_011694
Chloride ion current inducer
protein
U53455
Interleukin 12 receptor, beta 1 NM_008353
Integral membrane protein 2B NM_008410
Integrin alpha 7 NM_008398
Regulation of cell cycle G two S phase expressed
protein 1 (Gtse 1)
NM_013882
Microtubule-associated protein,
RP/EB family, member 1
NM_007896
Casein kinase II, alpha 2,
polypeptide
NM_009974
Metabolic enzymes N-deacetylase/
N-sulfotransferase 2
NM_010811
Beta-1,4-N-acetyl-galactosaminyl
ransferase 1 (Galgt1)
NM_008080
Ketohexokinase (KhK) NM_008439
Protein phosphorylation Protein phosphatase 1, regulatory
(inhibitor) subunit 14B
NM_008889
Proteolysis and
peptidolysis
Matrix metalloproteinase-2 NM_008610
Matrix metalloproteinase-9 NM_013599
Disintegrin and metalloprotease
domain 3 (cyritestin)
NM_009619
Tissue inhibitor of
metalloproteinase 1
NM_011593
Tissue inhibitor of
metalloproteinase 2
NM_011594
Tissue inhibitor of
metalloproteinase 3
BC014713
Tissue inhibitor of
metalloproteinase 4
NM_080639
According to the microarray and quantitative real-time polymerase chain
reaction (QRT-PCR) analysis 36 genes showed altered expression after 60 and
120 min of perfusion of mouse hearts.
Table 5
Cardiac functional parameters in control and perfused groups
5′
(mean)
5′
(SEM)
60′
(mean)
60′
(SEM)
120′
(mean)
120′
(SEM)
Heart rate
(beats/min)
437 23 443 20 424 11
Coronary flow
(ml/min)
3.3 0.3 3.3 0.2 3.2 0.2
Heart weight
(mg)
163 6 163.5 6 149.8 9
Hemodynamic parameters, like coronary flow and heart rate were also
measured. None of these parameters changed in the perfused groups when
compared to controls.
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regulated in the mouse heart. Acyl-CoA dehydrogenases
(ACADs) are a family of mitochondrial enzymes catalyzing
the initial rate-limiting step in the beta-oxidation of fatty acyl-
CoA (Thorpe & Kim, 1995). This reaction provides the main
source of energy for human heart and skeletal muscle.
Deficiency of the long-chain Acyl-CoA dehydrogenase
(LCAD), usually leads to human organic diseases, such as
sudden death in infancy, cardiomyopathy and hypoketotic
hypoglycemia (Zhang et al., 2002). In our study we have
detected a significant fall in LCAD transcription rate, but only
after 2 h of perfusion.
Decreased mRNA levels of chloride ion current inducer were
detected after 60 and 120 min of normoxic perfusion. This gene
has already been studied in rat brain and myocardium, but the
gene function only described in ocular ciliary epithelium
(Anguita, Chalfant, Civan, Coca-Prados , 1995; Wan, Chen,
& Sears, 1997).
Genes, coding for two apoptotic proteins presented significant
repression in response to perfusion. One of them, the gene,
encoding Integral membrane protein 2B is supposedly connected
with the development of dementia (Wolfe et al., 1999). The other
apoptotic gene, voltage-dependent anion channel1 (Vdac1)
exhibited one of the most pronounced repressions due to
perfusion. Previously Anflous, Armstrong, and Craigen (2001)
proved that Vdac1 was required for creatine stimulation of
mitochondrial respiration in oxidative muscles. As the micro-
array and the QRT-PCR results evidenced, repression rate of
Vdac1 increases directly proportional to the increase in per-
fusion time.
Perfusion repressed several genes including some signal
transduction genes. One of them, the integrin alpha 7 didn't
show altered expression after 60 min of perfusion, but after
120 min it was strongly repressed. Integrin alpha 7 is a specific
cellular receptor for the basement membrane protein Laminin-1,
as well as for the Laminin isoforms 2 and 4. The alpha 7 subunit
is expressed mainly in skeletal and cardiac muscle and has been
suggested to be involved in differentiation and migration
processes during myogenesis. Mayer et al. (1997) studied the
involvement of Integrin alpha 7, during myogenesis and its role
in muscle integrity and function. They proved that absence of
this protein causes muscular dystrophy.
The interleukin 12 receptor beta-1 gene also represents
strongly attenuated function correlated to the control in both
groups. Myocardial function of that is not known yet, but recently
Kutukculer et al. (2006) associated the interleukin-12 receptor
beta-1 deficiency with cutaneous leukocytoclastic vasculitis.
The gene coding A disintegrin and metalloprotease domain 3
(Adam3) had a very significant rise in transcription rate. This
gene may play a role in cell–cell and cell–matrix interactions
during spermatogenesis. The myocardial role of Adam3 is not
known so far, but Adam10, Adam15 and Adam19 from the
same gene family demonstrably show altered expression dur-
ing cardiomyopathy (Fedak, Moravec, & McCarthy, 2006;
Kurohara, Komatsu, Kurisaki, & Masuda, 2004).
Protein phosphatase 1 regulatory subunit 14B became
repressed only after 120 min of perfusion. Ppp1r14b provides
a regulator function by controlling protein phosphatases.
Two genes have shown altered expression among the muscle
contraction regulators. Our results showed that 60 and 120 min
of perfusion also induce repression of creatine kinase muscle
(ckmm). Ckmm is expressed by various tissue types. Its function
is the catalysis of the conversion of creatine to phosphocreatine,
consuming ATP and generating ADP. Andres, Sharma, and
Sassen (1993) realised that this key enzyme of intracellular
energy transduction is altered in porcine myocardium subjected
to repeated brief periods of ischemia, but they haven't noticed
any changes in ckmm gene expression during perfusion.
The repression rate of troponin T1 skeletal (tnnt1) rose with
the increase of perfusion time in our present study. Tnnt1 can be
found principally in skeletal muscle. Troponin T2 with similar
structure and functions has previously represented altered
expression in response to ischemia-reperfusion and it is suitable
to detect myocardial injuries (Sobki, Saadeddin, & Habbab,
2000).
4.2. Expression profiling of genes related to ischemic adaptation
Expression rate at mRNA level of an additional 19 genes
(Table 3) strongly related to cardiac adaptation to ischemia-
reperfusion but not available on the microarrays was also
investigated by QRT-PCR (Table 3).
During reperfusion, when blood supply returns to the tissue
after a period of ischemia, the absence of oxygen and nutrients
from blood creates a condition in which the restoration of
circulation results in inflammation and oxidative damage from
the oxygen rather than restoration of normal function. This
oxidation results that molecular oxygen being converted into
highly reactive superoxide and hydroxyl radicals. The aim of
our study was to identify those genes that changed only due to
perfusion.
Superoxide dismutase (SOD) catalyzes the reduction of
superoxide anions to hydrogen peroxide and, as such, it is an
important antioxidant. SOD is an intracellular enzyme present
essentially in every cell of the body. Three SOD isoenzymes are
known characterized by different metal content (Ferdinandy &
Schulz, 2003). According to our results each type of SOD
shows over-expression after 60 and 120 min of perfusion.
Yoshida, Maulik, Engelman, and Ho (2000) previously proved
that SOD I (−/−) mouse hearts are more susceptible to ischemic
reperfusion injury compared with corresponding wild-type
mouse hearts, suggesting that the sod1 gene constitutes an
important defense element for the hearts.
NADPH oxidase is a multi-subunit enzyme that catalyzes the
reduction of molecular oxygen to superoxide. Superoxide (and
associated reactive oxygen species, ROS) generated by NADPH
oxidase in non-phagocytic cells serves several functions in
health and disease (Cave et al., 2006). A major concept in redox
signaling is that while NADPH oxidase-derived ROSs are
necessary for normal cellular function, excessive oxidative
stress can contribute to pathological disease (Infanger, Sharma,
& Davisson, 2006). According to our results, the over-
expression of NOX enzymes (and by this way the amount of
reactive oxygen species) increase directly proportional to
perfusion time.
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Matrix metalloproteinases (MMPs) are Zn-dependent endo-
peptidases. Collectively they are capable of degrading many
extracellular matrix proteins, but also can process a number of
bioactive molecules (Chow, Cena, & Schulz, 2007). They are
known to be involved in the cleavage of cell surface receptors,
release of apoptotic ligands and chemokine activation. MMPs
are also thought to play a major role on other cell behaviors such
as cell proliferation, migration, differentiation, angiogenesis,
apoptosis and host defense. We observed increased mRNS
levels in case of two matrix metalloproteinase genes; mmp2
and mmp9. Matrix metalloproteinases 2 and 9 (MMP-2 and
MMP-9) are increased in the rat brain after experimental
ischemic stroke and they also contribute to myocardial remod-
eling after myocardial infarction (Machado et al., 2006; Mori,
Gibson, & McTiernan, 2006) as well as in the development of
acute infarction (Giricz et al., 2006). In our study these genes
exhibited almost the most pronounced over-expressions due to
perfusion.
We also detected increasing gene expression at the gene for
low density lipoprotein. LDL cholesterol is the so called “bad”
cholesterol, which carries mostly fat and only a small amount of
protein from the liver to other cell types of the body. A high
LDL cholesterol level is considered a risk factor for coronary
artery disease because, under certain conditions, it leads to
atherosclerosis and interferes with cardioprotective mechanisms
(Ferdinandy, Schulz, & Baxter, 2007). Oxidative modification
of lipoproteins appears to play an important role in the
atherogenic process. oxLDL is involved in inducing smooth
muscle cell migration and proliferation, and are avidly ingested
by macrophages, resulting in foam cell formation (Mertens &
Holvoet, 2002). Our results suggest that the expression of LDL
rises during perfusion and due to the perfusion-formed radicals
LDL changes into its oxidating form (oxLDL). Geranyl geranyl
transferase, hmg-CoA reductase, farnesyl diphosphate farnesyl
transferase 1 genes involved in cholesterol biosynthesis
exhibited up-regulation due to perfusion.
Tissue inhibitor of metalloproteinase (TIMP) enzymes play
an important role in histogenesis and organogenesis (Werb &
Chin, 1998). Matrix metalloproteinases are proteolytic enzymes
which degrade extracellular matrix and basement membrane.
Tissue inhibitor of metalloproteinases are the specific inhibitors
of MMPs. Circulating levels of MMPs and TIMPs could reflect
the atherosclerotic process occurring within the arterial wall and
have been identified in normal and failing myocardium
(Spinale, 2002). Recent studies suggest that MMPs and
TIMPs play a role in various cardiovascular diseases including
atherosclerosis and ventricular remodeling observed in heart
failure (Mori et al., 2006).
The nitric oxide synthases (NOS) are a group of enzymes
responsible for the synthesis of nitric oxide (NO) from the
terminal nitrogen atom of L-arginine in the presence of O2 and
further cofactors. Nitric oxide plays role in many physiological
function and pathological states of the heart (Ferdinandy &
Schulz, 2003).We have shown that perfusion inhibits expression
of cardiac nos2, but activates the expression of nos1.
Heat shock proteins are interesting new target for cardio-
protection (Sőti et al., 2005) The 25-kDa heat-shock protein
(Hsp25) is expressed in the cartilage of the growth plate and
suggested to function in chondrocyte differentiation and
degeneration. It has demonstrably have cardioprotective effect,
but the detailed mechanism is not known yet (Chiu & Ko,
2004). Our present results show that 60 and 120 min of
perfusion induce over-expression of hsp25.
5. Limitations of the study
The stability of the preparation upon long-term perfusion is
a general concern in isolated heart preparations. Here we used
a Langendorff preparation with no left ventricular balloon to
unload the heart from ‘afterload pressure’ and to maintain a
good coronary perfusion throughout the perfusion protocol. As
shown in Table 5, heart rate and coronary flow were stable
which show the stable aerobic condition of the heart. As the
present study was performed in crystalloid-perfused isolated
mouse hearts and the analysis of gene expression was done
using cardiac tissue that did not contain components of blood,
cellular regulatory pathways might be somewhat different
in the present ex vivo experimental model as compared to
in vivo situations. Perfusion with blood might solve this
issue, however, blood perfusion can be a problem in itself
(Clements-Jewery et al., 2002). In our present studies, to avoid
spontaneous occurrence of arrhythmias, we used a perfusion
buffer containing high potassium. Since the gene expression
pattern in mice hearts were measured first at 60 min, the
results might not be relevant for e.g. studies on ischemia-
induced arrhythmias which need shorter perfusion time (Curtis,
1998). It is of interest, however, that in isolated hearts, phase
2 ischaemic arrhythmias are not observed (Ravingerová,
Tribulová, Slevák, & Curtis, 1995). This could be due to the
extensive changes in gene expression observed in the present
study. It should be noted that the gene expression changes
observed here may be specific for isolated mice heart perfusion
and the results have less relevance in heart perfusion
preparations in other species.
6. Conclusions
Our results show that normoxic crystalloid perfusion itself
results in time-dependent changes in cardiac gene expression.
As many of these genes with altered expression have been
suspected to influence several cardiovascular pathologies, this
should be considered when designing ex vivo perfusion
protocols in the mouse heart to study cardiac diseases.
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